Larry Cripe is an Oncology physician affiliated with Indiana University Health. OpenAlex indexes 192 publications with 6,488 citations (h-index 35); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
535 Barnhill Dr
Rt 473
Indianapolis, IN 462025112
Telephone
317-278-1186Provider last certified this registry record 6 Mar 2025.
Clinical trials
- Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Sponsor: Eastern Cooperative Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- PFIZER INC.Program year20241 payment
- Seagen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2000–2008 per NIH RePORTER. The latest:
- SINGLE-CENTER PHASE I STUDY TO DETERMINE THE OPTIMAL BIOLOGIC DOSE OF CC-401
Indiana University Indianapolis
FY2008$29M01RR000750 - SINGLE-CENTER PHASE I STUDY TO DETERMINE THE OPTIMAL BIOLOGIC DOSE OF CC-401
Indiana Univ-Purdue Univ at Indianapolis
FY2007$342M01RR000750 - ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSION
Indiana Univ-Purdue Univ at Indianapolis
FY2006$404M01RR000750
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024
Journal of the National Comprehensive Cancer Network
2024 - Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience
American Journal of Hematology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Sravanti Rangaraju, MBBS
Indiana University Health
Martin Earle, MD
Indiana University Health
Martin Farlow, MD
Indiana University Health
Lawrence Einhorn, MD
Indiana University Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”